WEBs QQQ Defined Volatility ETF (DVQQ)
Live price chart, market sentiment, and community perspectives for WEBs QQQ Defined Volatility ETF (NASDAQ: DVQQ).
Live price chart, market sentiment, and community perspectives for WEBs QQQ Defined Volatility ETF (NASDAQ: DVQQ).
On our desk, DVQQ looks less like a core growth allocation and more like a micro-cap liquidity trap. Even though the fund posted a decent trailing 1-year return, the AUM sitting around $2 million to $3.5 million with an average daily volume of roughly $148,000 creates unacceptable exit friction under market stress. Watching short interest spike by nearly 687% in July to 6.8% of shares outstanding tells me that sophisticated shorts are circling an overly narrow, 4-holding vehicle. If you are deploying capital here, the lack of depth in the order book makes execution risk a primary concern.
As a quantitative analyst parsing the risk metrics, DVQQ presents a fascinating contradiction. The fund carries 1-year and 2-year betas above 1.1, implying it amplifies market swings relative to its Large Growth peers. Yet, Morningstar bafflingly rates its category risk as Low across 3Y, 5Y, and 10Y windows—despite the fact that the fund barely has a track record to substantiate multi-year readings. Furthermore, it trades below all major moving averages (MA50, MA150, MA200) and has slid over 7.5% year-to-date. Investors are getting low relative returns for taking on these compressed, illiquid structures.
From our compliance and institutional tracking perspective, 13F filings for Q2 2026 show only 4 institutional filers holding a meager $642K total in DVQQ. With only 3 new positions opened and 2 completely exited, broader institutional sponsorship is virtually non-existent. When evaluating niche defined-volatility wrappers like this or its stablemate DVSP, portfolio managers must factor in the 0.94% expense ratio against an extremely shallow asset base. Until AUM scales significantly and secondary market liquidity improves, standard operational protocols dictate avoiding unproven ETF structures with fewer than 150,000 shares outstanding.
Explore plasma cleansing, somatic organ swaps, and BCI.